Genetic and epigenetic concept of SARS-CoV-2 targets in different renal cancer subtypes
dc.authorid | Ilikci Sagkan, Rahsan/0000-0003-3844-6158 | |
dc.contributor.author | Akin-Bali, Dilara Fatma | |
dc.contributor.author | Sagkan, Rahsan Ilikci | |
dc.date.accessioned | 2024-11-07T13:32:23Z | |
dc.date.available | 2024-11-07T13:32:23Z | |
dc.date.issued | 2021 | |
dc.department | Niğde Ömer Halisdemir Üniversitesi | |
dc.description.abstract | Objectives: Recent advances in defining the genetic landscape of has shown the host cell-SARS-CoV-2 interaction via ACE2 protein and the presence of at least three additional virus invasion genes including TMPRSS2, FURIN, CD147/BSG. In current study, we investigated the mutation and m-RNA expression patterns of target genes by evaluating the associations between genetic and epigenetic mechanisms in the target genes and susceptibility of SARS-CoV-2 infection of renal cancer subtypes. Methods: We investigated the mutation and m-RNA expression patterns of our target genes. The promoter methylation profiles of target genes were tested in the UALCAN database. Results: The total rate of carrying genetic anomaly in the target genes including was 1.6% and seven mutations, one of which had a pathogenic feature, were detected. The expression analysis results in renal cancer groups showed that while the KIRC and KIRP patients had a lower level of TMPRSS2 than the healthy control, their ACE2 level was high. KICH patients had a higher level of CD147/BSG expression than the healthy group. The promoter methylation levels of ACE2 in KIRC and KIRP were reduced. Conclusions: We concluded that renal cancer patients may be more sensitive to SARS-CoV-2 infection, which may worsen the prognosis. | |
dc.identifier.doi | 10.1515/tjb-2020-0233 | |
dc.identifier.endpage | 155 | |
dc.identifier.issn | 0250-4685 | |
dc.identifier.issn | 1303-829X | |
dc.identifier.issue | 2 | |
dc.identifier.scopus | 2-s2.0-85106214090 | |
dc.identifier.scopusquality | Q4 | |
dc.identifier.startpage | 145 | |
dc.identifier.trdizinid | 492670 | |
dc.identifier.uri | https://doi.org/10.1515/tjb-2020-0233 | |
dc.identifier.uri | https://search.trdizin.gov.tr/tr/yayin/detay/492670 | |
dc.identifier.uri | https://hdl.handle.net/11480/15379 | |
dc.identifier.volume | 46 | |
dc.identifier.wos | WOS:000646210300004 | |
dc.identifier.wosquality | Q4 | |
dc.indekslendigikaynak | Web of Science | |
dc.indekslendigikaynak | Scopus | |
dc.indekslendigikaynak | TR-Dizin | |
dc.language.iso | en | |
dc.publisher | Walter De Gruyter Gmbh | |
dc.relation.ispartof | Turkish Journal of Biochemistry-Turk Biyokimya Dergisi | |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | |
dc.rights | info:eu-repo/semantics/openAccess | |
dc.snmz | KA_20241106 | |
dc.subject | ACE2 | |
dc.subject | CD147/BSG | |
dc.subject | COVID-19 | |
dc.subject | FURIN | |
dc.subject | methylation | |
dc.subject | renal cancer | |
dc.subject | Severe acute respiratory syndrome coronavirus 2 | |
dc.subject | TMPRSS2 | |
dc.title | Genetic and epigenetic concept of SARS-CoV-2 targets in different renal cancer subtypes | |
dc.title.alternative | Farklı böbrek kanseri alt tiplerinde SARS-CoV-2 hedeflerinin genetik ve epigenetik konsepti | |
dc.type | Article |